• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
  • MANUFACTURERS
  • HEADHUNTERS
  • PRODUCT LIBRARY
  • COMPANIES

SPINEMarketGroup

Spine Industry News

  • HOME
  • 2025
  • 2024
  • BROCHURES
  • ARTICLES

Xstim, Inc. Receives FDA Approval for Xstim™ Spine Fusion Stimulator

April 16, 2024 By SPINEMarketGroup

IRVING, Texas, April 16, 2024 /PRNewswire/ — Xstim, Inc., a pioneering developer and manufacturer of cutting-edge bone growth stimulation systems, is thrilled to announce its recent Premarket Application (PMA) approval from the U.S. Food and Drug Administration (FDA) for Xstim™ Spine Fusion Stimulator. Engineered with patient comfort and convenience in mind, the Xstim™ Spine Fusion Stimulator represents a significant milestone in the company’s product lineup of bone growth stimulators. This capacitively coupled device emits a low-energy signal clinically proven to promote bone healing after spinal fusion surgery1. Commercial availability of the Xstim device is slated for the second quarter of this year, with a targeted and phased launch plan in place to ensure widespread accessibility.

The Xstim device has been meticulously designed to prioritize patient ease of use and wearability, offering a noninvasive alternative for indicated cases. With its intuitive interface and sleek design, featuring a large onboard color display, the Xstim device streamlines patient therapy management.

Dr. Adam Bruggerman, MD, commented on the significance of Xstim, stating, “Bone healing following spinal fusion surgery is paramount to successful patient outcomes. The availability of non-invasive bone growth stimulation options like Xstim provides my patients with an invaluable advantage. Its sleek design ensures simple therapy management without the hassle of downloading and managing extra apps.”

Jeremy Perkins, Chief Executive Officer of Xstim, Inc., expressed the company’s commitment to enhancing spinal fusion rehabilitation standards, saying, “Xstim, Inc. is dedicated to empowering patients and surgeons to elevate the quality of care in spinal fusion rehabilitation. The introduction of the Xstim Spine Fusion Stimulator represents the beginning of our robust pipeline of bone growth stimulation innovations. We are poised to collaborate with healthcare providers and distribution partners to enhance bone fusion outcomes and elevate patient satisfaction. This FDA approval underscores our leadership in and dedication to the bone growth stimulation market.”

About Xstim, Inc.
Xstim, Inc. is a progressive medical technology company dedicated to transforming bone growth stimulation solutions. Centered on innovation, patient well-being, and clinical effectiveness, its mission is to redefine the care benchmark in spinal fusion rehabilitation and beyond.

For prescribing information and more about Xstim, Inc., please visit www.xstimmed.com.

For Media Inquiries:

Tony Spyropouolos
Tony@xstimmed.com 

References:

  1. Goodwin CB, Brighton CT, Guyer RD, Johnson JR, Light KI, Yuan HA. A double-blind study of capacitively coupled electrical stimulation as an adjunct to lumbar spinal fusions. Spine. 1999;24(13):1349-1356.
(Visited 274 times, 25 visits today)

Filed Under: NEWS Tagged With: 2024

Primary Sidebar

PLATINUM SPONSORS

EXALTA 2LOGO-min
CENTINEL SPINE
logo paradigm spine
TSUNAMI MEDICAL
VIKTOR HEGEDUS
RUDISHAUER
A-SPINE
GLOBAL biomedica
Z-MEDICAL
NORMMED
EMINENT SPINE
GENESYS SPINE
LfC
NGMEDICAL
RUTHLESS SPINE
syntropiq logo
bauispinelogo2025
ispine

GOLD SPONSORS

GSMEDICAL2025
SPINEGUARD2025

POPULAR POSTS

  • Globus Medical: What’s Behind the Surprise Exit of…
  • Spine Market Leadership: Globus Pressures Medtronic…
  • Why Are Medical Device Giants Exiting or Losing…
  • BROCHURES
  • Johnson & Johnson Follows in Zimmer Biomet’s…
  • Globus Medical Reports Second Quarter 2025 Results
  • Globus, Life Spine, and the Patent Battleground: Who…
  • Globus Medical, Inc. Secures Jury Verdict in…
  • (UPDATED 2025): 6 Artificial Cervical Discs You’ll…
  • The Quiet Return of the Viscogliosi Brothers to…
  • Globus Medical Announces Leadership Transitions and…
  • (UPDATED 2025): Starting Spine Endoscopy? Best…
  • Smart Implants, Connected Care: The Next Generation…
  • (2025 Update): Market, Leading FDA-Approved Devices,…
  • Johnson & Johnson Announces Intent to Separate…
  • Highridge Moves Fast, Acquires Key Spine Assets –…
  • Thinking About a Spine Robot? Your 2025 Guide to the…
  • Ruthless Spine Announces Intellectual Property News…
  • Managing Early-Onset Scoliosis: Which…
  • All Charges Dismissed Against Dr. Kingsley R. Chin…
  • LAST 5 VIDEOS PUBLISHED

      1. Surgical Theater: SyncAR
      2. Intelligent Implants: SmartFuse
      3. Implanet: Zeus
      4. Intrinsic Therapeutics: Barricaid
      5. Zygofix: zLOCK™

     

    Subscribe to Our Newsletter!

    Check your inbox or spam folder to confirm your subscription.

    Footer

    Contact us:

    spinemarketgroup@gmail.com info@thespinemarketgroup.com

    • LinkedIn
    • Twitter
    • YouTube

    PRIVACY POLICY

    • Legal

    Copyright © 2025 · SPINEMarketGroup